With programs spanning neuropsychiatry and #neurodegeneration, we’re committed to advancing medicines targeting novel MOAs with the goal of improving the lives of the millions of people living with brain diseases. Learn more about each program below.
Neumora
Biotechnology Research
Watertown, MA 12,291 followers
Pioneering a new era of medicines for brain diseases
About us
Brain diseases collectively represent one of the largest areas of unmet medical need, affecting upwards of 1.5 billion patients globally. Neumora was founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. Our goal is to redefine neuroscience drug development by bringing forward the next generation of novel therapies that offer improved treatment outcomes and quality of life for patients. We’ve built a pipeline comprised of programs for neuropsychiatric disorders and neurodegenerative diseases, each targeting a novel mechanism of action where we can leverage our precision neuroscience approach. Our pipeline currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Neumora is committed to addressing some of the most prevalent brain health disorders and transforming the standard of care for millions of patients living with brain diseases. Learn more about Neumora and career opportunities on our website below.
- Website
-
https://www.neumoratx.com
External link for Neumora
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Watertown, MA
- Type
- Privately Held
- Founded
- 2020
Locations
-
Primary
65 Grove Street, Suite 102
Watertown, MA 02472, US
Employees at Neumora
-
Matthew Fust
Independent Advisor to Life Sciences Companies
-
Karla Zeitz
-
Marco Giorgetti, PhD
Drug Discovery - Drug Development - Asset Strategy - Strategic Alliance Management - Neuroscience - Oncology
-
Sunita Malhotra
Senior Director, Alliance Management, Business Development, Opportunity Scouting
Updates
-
#Alzheimers impacts millions of people, and that number is only expected to grow. Alzheimer’s & Brain Health Awareness Month serves as a reminder of the significant unmet medical need that remains in AD. We are proud to be part of the effort to make a difference.
-
-
Today is Global ALS Awareness Day. If you or a loved one has been diagnosed with #ALS, you are not alone. Visit the below organizations for support and information. The ALS Association spearheads nationwide advocacy work, provides guidance on navigating this condition and more. ALS Network provides care services and hosts expert panels to support families affected by ALS.
-
-
Today, we are pleased to announce we have initiated a Phase 1b clinical study with NMRA-511 in #Alzheimers Disease agitation. Find full details here: https://lnkd.in/e-6x74dz
-
-
Recently, Neumora parents were invited to have special guests accompany them to work: their kids! Team members hosted hands-on experiments and brain science breakdowns to introduce Neumora’s work in brain disease and the abundance of meaningful career opportunities in STEM to our next generation of scientists. Check out some of our favorite moments.
-
-
In honor of #MentalHealthMonth, last month the Neumora team was encouraged to participate in wellness challenge bingo, with winners selected each week. No matter how long, taking the moment for yourself is worth it. Check out some of the activities on our bingo boards!
-
-
Our brains are the epicenter of everything we do - from making decisions and solving problems, to laughing at a coworker’s joke. June is #Alzheimers and Brain Health Awareness Month. The goal of this month is to raise awareness of how Alzheimer’s Disease affects people and their families, and educate on the importance of brain health. Learn more below.
-
#MentalHealthMonth is coming to a close, but our commitment to improving the lives of those living with these brain diseases does not end. We are proud to continue partnering with the mental health advocacy community to confront the brain disease crisis, including pursuing the development of novel treatment options for those who need them most.
-